Ingemar Turesson
1 – 10 of 123
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Autoimmune disease is associated with a lower risk of progression in monoclonal gammopathy of undetermined significance
(
- Contribution to journal › Article
-
Mark
A nationwide study on inpatient opportunistic infections in patients with chronic lymphocytic leukemia in the pre-ibrutinib era
(
- Contribution to journal › Article
-
Mark
Untangling fracture risk in monoclonal gammopathy of undetermined significance : A population-based cohort study
(
- Contribution to journal › Article
-
Mark
Cumulative exposure to melphalan chemotherapy and subsequent risk of developing acute myeloid leukemia and myelodysplastic syndromes in patients with multiple myeloma
(
- Contribution to journal › Article
-
Mark
Comorbidities in multiple myeloma and implications on survival : A population-based study
(
- Contribution to journal › Article
- 2020
-
Mark
Monoclonal gammopathy of undetermined significance in medical hospital admissions – a new strategy for screening?
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Excluding myeloma diagnosis using revised thresholds for serum free light chain ratios and M-protein levels
(
- Contribution to journal › Letter
-
Mark
A population-based study on serious inpatient bacterial infections in patients with chronic lymphocytic leukemia and their impact on survival
(
- Contribution to journal › Article
-
Mark
Outcome and characteristics of non-measurable myeloma : A cohort study with population-based data from the Swedish Myeloma Registry
(
- Contribution to journal › Article
-
Mark
Second malignancies in multiple myeloma; emerging patterns and future directions
(
- Contribution to journal › Scientific review